Found: 6
Select item for more details and to access through your institution.
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00962-z
- By:
- Publication type:
- Article
Targeting the β<sub>2</sub>‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
- Published in:
- Journal of Pathology, 2023, v. 259, n. 1, p. 69, doi. 10.1002/path.6020
- By:
- Publication type:
- Article
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1727, doi. 10.3390/cancers11111727
- By:
- Publication type:
- Article
Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01699-3
- By:
- Publication type:
- Article
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00566-8
- By:
- Publication type:
- Article
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
- Published in:
- Theranostics, 2024, v. 14, n. 7, p. 2656, doi. 10.7150/thno.91456
- By:
- Publication type:
- Article